26 completed, 2 unknown, 1 recruiting. 9 Phase 3, 7 Not applicable, 6 Phase 2, 5 Phase 1, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
| Not applicable | 7 | Completed 4, Unknown 2, Recruiting 1 |
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 5 | Completed 5 |
| Phase 4 | 2 | Completed 2 |
Follow Head Lice: new trials by email Literature Review of Head Lice trials Research Report on Head Lice
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo Elimax Green Lotion with Emogreen, Walgreens Lice Killing Shampoo - Head Lice | Not applicable | Recruiting | Oystershell NV | 86 | 2025-10-02 | 2025-09-24 |
| A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation Vamousse Spray 'n' Go, Nix Creme Rinse Lice Treatment - Pediculosis Capitis, Lice Infestations | Phase 4 | Completed | Alliance Pharmaceuticals | 58 | 2022-12-15 | 2025-02-24 |
| Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation INVESTIGATIONAL DEVICE, Comparator device - Head Lice | Not applicable | Unknown | Perrigo CSCI | 136 | 2022-05-18 | 2022-06-01 |
| A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product. X92001752, RID Super Max Solution, Nix Crème - Head Lice, Pediculosis Capitis | Not applicable | Unknown | Oystershell NV | 220 | 2022-01-17 | 2022-09-21 |
| A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product. X92001666, RID shampoo - Head Lice, Pediculosis Capitis | Not applicable | Completed | Oystershell NV | 70 | 2018-03-07 | 2022-07-05 |
| Clinical Endpoint Study of Ivermectin 0.5% Lotion Generic Ivermectin Lotion 0.5%, Sklice® (Ivermectin) Lotion 0.5%, Vehicle Lotion - Head Lice | Phase 3 | Completed | Actavis Inc. | 905 | 2017-10-07 | 2019-12-20 |
| A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice Ivermectin 0.5% Topical Application Lotion, Ivermectin 0.5% Topical Application Lotion [SKLICE], Placebo 0% Lotion - Head Lice | Phase 3 | Completed | Mayne Pharma International Pty Ltd | 296 | 2017-10-02 | 2020-09-17 |
| Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands Ivermectin, Permethrin 5%, Malathion Shampoo 0.5% - Scabies, Head Lice | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 118 | 2017-08-01 | 2019-06-14 |
| Bioequivalence Study for Benzyl Alcohol Lotion 5%. Benzyl Alcohol Lotion 5%, Ulesfia (benzyl alcohol lotion) 5%, Placebo - Head Lice | Phase 3 | Completed | Akorn, Inc. | 239 | 2015-08-01 | 2021-01-27 |
| Safety and Efficacy of a Head Lice Shampoo Pyrethrum Extract, Silcap Shampoo - Head Lice | Not applicable | Completed | Oystershell NV | 109 | 2014-10-13 | 2024-03-27 |
| Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion Abametapir Lotion 0.74% w/w, Sodium Lauryl Sulfate, Saline 0.9% - Head Lice | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 40 | 2014-01-01 | 2021-07-26 |
| Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion Abametapir Lotion 0.74% w/w, 0.1% sodium lauryl sulfate, saline 0.9% - Head Lice | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 238 | 2014-01-01 | 2020-04-29 |
| A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice X92001327, RID shampoo - Head Lice | Not applicable | Completed | Oystershell NV | 60 | 2013-03-05 | 2018-04-05 |
| A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation Ivermectin Cream, vehicle control - Head Lice | Phase 3 | Completed | Topaz Pharmaceuticals Inc | 410 | 2010-03-01 | 2012-04-06 |
| A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects 0.5% Ivermectin Cream, Placebo control - Head Lice | Phase 3 | Completed | Topaz Pharmaceuticals Inc | 371 | 2010-03-01 | 2012-04-06 |
| Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application NeutraLice Lotion, NeutraLice Advance Solution, Moov Head Lice Solution - Head Lice | Phase 4 | Completed | Altman Biomedical Consulting Pty. Ltd. | 90 | 2009-10-01 | 2010-07-28 |
| Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects Ivermectin cream, vehicle control - Head Lice | Phase 2 | Completed | Topaz Pharmaceuticals Inc | 264 | 2009-10-01 | 2012-04-06 |
| A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age 0.5% Ivermectin Cream - Head Lice | Phase 1 | Completed | Topaz Pharmaceuticals Inc | 30 | 2009-09-01 | 2012-04-25 |
| Pediatric Head Lice Study Product Comparison LICEMD, Standard Head lice product - Head Lice | Phase 2 | Completed | Hackensack Meridian Health | 97 | 2009-05-01 | 2016-07-29 |
| NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers NatrOVA Creme Rinse - 1%, NatrOVA Creme Rinse Vehicle Only, Blank Patch - Head Lice | Phase 1 | Completed | ParaPRO LLC | 65 | 2008-01-01 | 2008-08-04 |
Showing 20 of 29. Sign in to see all of them.
Lice Infestations (4) · Parasitic Diseases (1) · Scabies (1)
Ectoparasitic Infestations (5) · Infections (5) · Skin Diseases (5) · Skin Diseases, Infectious (5) · Skin Diseases, Parasitic (5) · Skin and Connective Tissue Diseases (5) · Parasitic Diseases (4) · Mite Infestations (1)
Ivermectin (3) · Permethrin (3) · Sodium Chloride (2) · Sodium Dodecyl Sulfate (2) · Benzyl Alcohols (1) · Ethanol (1) · Hexachlorocyclohexane (1) · Malathion (1) · spinosad (1)
Oystershell NV (6) · ParaPRO LLC (4) · Topaz Pharmaceuticals Inc (4) · Summers Laboratories (3) · Dr. Reddy's Laboratories Limited (2) · Actavis Inc. (1) · Akorn, Inc. (1) · Alliance Pharmaceuticals (1) · Altman Biomedical Consulting Pty. Ltd. (1) · Boston Scientific Corporation (1) · Hackensack Meridian Health (1) · London School of Hygiene and Tropical Medicine (1) · Mayne Pharma International Pty Ltd (1) · Medical Entomology Centre (1) · Perrigo CSCI (1)
United States (23) · Australia (1) · Germany (1) · Mauritius (1) · Solomon Islands (1) · United Kingdom (1)
Anne Lucky, Dr. (2) · E.A. Clark, Dr. (2) · Jon Thomas, Dr. (2) · Jonathan Dosik (2) · Peter E Silas, Dr. (2) · Terri Meinking (2) · Dyal Garg, Ph.D. (1) · Elisabeth Rivera (1) · Elisabeth Rivera, CPI (1) · Ian F Burgess (1) · Ian F Burgess, M.Phil. (1) · Jeffrey Boscamp, MD (1) · John V Murray, MD (1)
PMID 20199404, PMID 23113480, PMID 26092045, PMID 30252856, PMID 30506361